Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Rapamycin and Regulatory T Cells in Kidney Transplantation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Carmelo Libetta, IRCCS Policlinico S. Matteo
ClinicalTrials.gov Identifier:
NCT01014234
First received: November 13, 2009
Last updated: March 24, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)